1. Companies to review manufacturing of sartans

   News item 16 February 2019 Pages: 1 - 1

2. Personal-use devices to measure warfarin levels inaccurate

   News item 16 February 2019 Pages: 2 - 2

3. Prolonged hydrochlorothiazide use linked with skin cancer

   News item 16 February 2019 Pages: 3 - 3

4. Recent CPM updates highlighted by Health Canada

   News item 16 February 2019 Pages: 4 - 4

5. New initiative protects European public from fake medicines

   News item 16 February 2019 Pages: 5 - 5

6. Andexanet-α reduces anti-factor Xa activity, improves haemostasis

   Clinical study 16 February 2019 Pages: 6 - 6

7. Detection of chemotherapy prescribing errors

   Clinical study 16 February 2019 Pages: 7 - 7

8. Haemorrhage with antiplatelet drugs with DOACs vs VKAs

   Clinical study 16 February 2019 Pages: 8 - 8

9. Inappropriate prescribing in elderly increases costs and AEs

   Clinical study 16 February 2019 Pages: 9 - 9

10. Ranolazine: risk of seizures early after treatment initiation

    Clinical study 16 February 2019 Pages: 10 - 10

11. Safety monitoring of Shingrix recombinant zoster vaccine

    Clinical study 16 February 2019 Pages: 11 - 11

12. Vaccination-related deaths in China

    Clinical study 16 February 2019 Pages: 12 - 12

13. Lactobacillus rhamnosus

    Case report 16 February 2019 Pages: 13 - 13

14. Aclarubicin/Antineoplastics

    Case report 16 February 2019 Pages: 14 - 14

15. Adalimumab

    Case report 16 February 2019 Pages: 15 - 15

16. Adalimumab/certolizumab pegol/etanercept

    Case report 16 February 2019 Pages: 16 - 16

17. Adalimumab/infliximab

    Case report 16 February 2019 Pages: 17 - 17

18. Aflibercept

    Case report 16 February 2019 Pages: 18 - 18

19. Albendazole

    Case report 16 February 2019 Pages: 19 - 19

20. Albumin human/cefepime/tramadol

    Case report 16 February 2019 Pages: 20 - 20

21. Albumin-human

    Case report 16 February 2019 Pages: 21 - 21

22. Alectinib/crizotinib

    Case report 16 February 2019 Pages: 22 - 22

23. Alemtuzumab

    Case report 16 February 2019 Pages: 23 - 23

24. Alemtuzumab

    Case report 16 February 2019 Pages: 24 - 24

25. Amantadine

    Case report 16 February 2019 Pages: 25 - 25

26. Amantadine/mirtazapine/nortriptyline

    Case report 16 February 2019 Pages: 26 - 26

27. Amphotericin B liposomal

    Case report 16 February 2019 Pages: 27 - 27

28. Amphotericin B liposomal/betamethasone

    Case report 16 February 2019 Pages: 28 - 28

29. Ampicillin

    Case report 16 February 2019 Pages: 29 - 29

30. Anti-CD19 CAR transduced T cells

    Case report 16 February 2019 Pages: 30 - 30

31. Antiasthmatics/magnesium sulfate

    Case report 16 February 2019 Pages: 31 - 31

32. Antibacterials/immunosuppressants

    Case report 16 February 2019 Pages: 32 - 32

33. Antidepressants/pirenzepine

    Case report 16 February 2019 Pages: 33 - 33

34. Antineoplastics

    Case report 16 February 2019 Pages: 34 - 34

35. Antineoplastics

    Case report 16 February 2019 Pages: 35 - 35

36. Antineoplastics

    Case report 16 February 2019 Pages: 36 - 36

37. Antineoplastics

    Case report 16 February 2019 Pages: 37 - 37

38. Antineoplastics

    Case report 16 February 2019 Pages: 38 - 38

39. Antineoplastics

    Case report 16 February 2019 Pages: 39 - 39

40. Antipsychotics interaction

    Case report 16 February 2019 Pages: 40 - 40

41. Antithymocyte globulin

    Case report 16 February 2019 Pages: 41 - 41

42. Antithymocyte globulin/atracurium besilate

    Case report 16 February 2019 Pages: 42 - 42

43. Antithymocyte globulin/cyclophosphamide

    Case report 16 February 2019 Pages: 43 - 43

44. Antithymocyte-globulin

    Case report 16 February 2019 Pages: 44 - 44

45. Antituberculars

    Case report 16 February 2019 Pages: 45 - 45

46. Apixaban/edoxaban

    Case report 16 February 2019 Pages: 46 - 46

47. Apremilast

    Case report 16 February 2019 Pages: 47 - 47

48. Aripiprazole

    Case report 16 February 2019 Pages: 48 - 48

49. Articaine/epinephrine

    Case report 16 February 2019 Pages: 49 - 49

50. Aspirin/dabigatran-etexilate/omega-3-fatty-acid interaction

    Case report 16 February 2019 Pages: 50 - 50